Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

LHCGR anticorps (N-Term) (CF®488A)

L’anticorps Souris Monoclonal anti-LHCGR a été validé pour IF, FACS et IHC. Il convient pour détecter LHCGR dans des échantillons de Humain.
N° du produit ABIN6165103

Aperçu rapide pour LHCGR anticorps (N-Term) (CF®488A) (ABIN6165103)

Antigène

Voir toutes LHCGR Anticorps
LHCGR (Luteinizing Hormone/Choriogonadotropin Receptor (LHCGR))

Reactivité

  • 73
  • 31
  • 23
  • 5
  • 5
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 51
  • 27
  • 1
Souris

Clonalité

  • 52
  • 27
Monoclonal

Conjugué

  • 33
  • 5
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp LHCGR est conjugé à/à la CF®488A

Application

  • 51
  • 30
  • 27
  • 22
  • 14
  • 13
  • 13
  • 10
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (IHC)

Clone

LHCGR-1417
  • Épitope

    • 22
    • 15
    • 6
    • 6
    • 6
    • 5
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term

    Fonction

    Mouse Monoclonal anti-Luteinizing Hormone / Choriogonadotropin Receptor (LHCGR/1417), CF488A Conjugate

    Attributs du produit

    This antibody recognizes a protein of 78-85 kDa, which is identified as luteinizing hormone/choriogonadotropin receptor. Luteinizing hormone plays a role in spermatogenesis and ovulation by stimulating the testes and ovaries to produce steroids. Choriogonadotropin production in the placenta maintains estrogen and progesterone levels during the first trimester of pregnancy. Ovaries and testes abundantly express luteinizing hormone/choriogonadotropin receptor (LHCGR) as a seven transmembrane, G protein-coupled receptor glycoprotein. LHCGR influences the protective effect of pregnancy and Gonadotropin against breast cancer. The expression of LHCGR on breast carcinoma correlates in part to the degree of tumor differentiation. LHCGR -positive breast tumors occur more frequently in tumors with greater cell differentiation in premenopausal women. Primary antibodies are available purified, or with a selection of fluorescent CF® dyes and other labels. CF® dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

    Immunogène

    Recombinant N-terminal fragment of human LHCGR (exact sequence is proprietary)

    Isotype

    IgG1 kappa
  • Indications d'application

    Immunohistology (formalin) 0.5-1 μg/mL
    • Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM citrate buffer,  pH 6.0, for 10-20 min followed by cooling at RT for 20 min
    • Flow Cytometry 0.5-1 μg/million cells/0.1 mL
    • Immunofluorescence 1-2 μg/mL
    • Optimal dilution for a specific application should be determined by user

    Commentaires

    HepG2 or Jurkat cells. Ovarian Carcinoma

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    100 μg/mL

    Buffer

    PBS/0.1 % BSA/0.05 % azide

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Conseil sur la manipulation

    Protect from light
  • Antigène

    LHCGR (Luteinizing Hormone/Choriogonadotropin Receptor (LHCGR))

    Autre désignation

    Luteinizing Hormone / Choriogonadotropin Receptor

    Poids moléculaire

    78-85 kDa

    ID gène

    3973, 468490

    UniProt

    P22888

    Pathways

    Regulation of Hormone Metabolic Process, Regulation of Hormone Biosynthetic Process, cAMP Metabolic Process, Glycosaminoglycan Metabolic Process, Regulation of Carbohydrate Metabolic Process, Autophagy, Negative Regulation of intrinsic apoptotic Signaling
Vous êtes ici:
Chat with us!